Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation
Author:
- 12 January 2010
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Metabolism & Toxicology
- Vol. 6 (2) , 115-131
Abstract
(2010). Engineering cytochrome P450 biocatalysts for biotechnology, medicine and bioremediation. Expert Opinion on Drug Metabolism & Toxicology: Vol. 6, No. 2, pp. 115-131.Keywords
This publication has 153 references indexed in Scilit:
- Enhancement of intratumoral cyclophosphamide pharmacokinetics and antitumor activity in a P450 2B11-based cancer gene therapy modelCancer Gene Therapy, 2007
- Statistical analysis of physical-chemical properties and prediction of protein-protein interfacesJournal of Molecular Modeling, 2007
- Re-engineering cytochrome P450 2B11dH for enhanced metabolism of several substrates including the anti-cancer prodrugs cyclophosphamide and ifosfamideArchives of Biochemistry and Biophysics, 2007
- Investigation of the role of cytochrome P450 2B4 active site residues in substrate metabolism based on crystal structures of the ligand-bound enzymeArchives of Biochemistry and Biophysics, 2006
- Preparation, Characterization, and Substrate Metabolism of Gold-Immobilized Cytochrome P450 2C9Journal of the American Chemical Society, 2006
- Enantioselective α-Hydroxylation of 2-Arylacetic Acid Derivatives and Buspirone Catalyzed by Engineered Cytochrome P450 BM-3Journal of the American Chemical Society, 2006
- Structure-Guided Recombination Creates an Artificial Family of Cytochromes P450PLOS Biology, 2006
- Protein stability promotes evolvabilityProceedings of the National Academy of Sciences, 2006
- Structural diversity of human xenobiotic-metabolizing cytochrome P450 monooxygenasesBiochemical and Biophysical Research Communications, 2005
- Formation of Indigo by Recombinant Mammalian Cytochrome P450Biochemical and Biophysical Research Communications, 1999